Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Aura Biosciences, Inc. (AURA) had Weighted-Average Shares Outstanding (Diluted) of 50.13M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-27.48M |
|
-- |
|
-- |
|
$29.04M |
|
$-29.04M |
|
$1.57M |
|
$-27.46M |
|
$-27.46M |
|
$-27.48M |
|
$-27.48M |
|
$-27.48M |
|
$-27.48M |
|
$-29.04M |
|
$-28.74M |
|
50.13M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
50.13M |
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$134.52M |
|
$3.11M |
|
$20.88M |
|
$155.40M |
|
$12.16M |
|
-- |
|
$15.27M |
|
$27.43M |
|
$127.97M |
|
$127.97M |
|
$127.97M |
|
50.23M |
|
| Cash Flow Statement Financials | |
$-23.36M |
|
$29.81M |
|
$0.10M |
|
$32.46M |
|
$38.99M |
|
$6.53M |
|
$3.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.48% |
|
-21.48% |
|
-17.69% |
|
-21.48% |
|
$2.55 |
|
$-0.47 |
|
$-0.47 |
|